Intravenous immunoglobulins (IVIg): complications
Evidence-based neurology checklist on intravenous immunoglobulins (ivig): complications: Thromboembolic stroke Onset Manifestations Management Headache Aseptic meningitis Flu-like symptoms Gastrointestinal complications Cardiovascular complications Dermatological complications Vasomotor…
Thromboembolic stroke
- Onset
- Manifestations
- Management
Headache
Aseptic meningitis
Flu-like symptoms
Gastrointestinal complications
Cardiovascular complications
Dermatological complications
Vasomotor complications
Other systemic complications
Laboratory complications
References
- Jiang M, Kimber JS, Gupta A, et al. Adverse reactions associated with intravenous immunoglobulin administration in the treatment of neurological disorders: a systematic review. Int Arch Allergy Immunol 2023; 184:513-528.
- Patwa HS, Chaudhry V, Katzberg H, et al. Evidence-based guideline: intravenous immunoglobulin in the treatment of neuromuscular disorders. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2012; 78:1009-1015.
- Association of British Neurologists. Guidelines for the use of intravenous immunoglobulin in neurological diseases. Revised 2005.
- Kapoor M, Spillane J, Englezou C, et al. Thromboembolic risk with IVIg: incidence and risk factors in patients with inflammatory neuropathy. Neurology 2020; 94:e635-e638.
- Rogers T, White LM, Cooper S, Smith H, Gosal D, Keh RYS. Thromboembolic risk of intravenous and subcutaneous immunoglobulin treatment for neuroinflammatory diseases. JNNP 2026; 97:204-208.
- And 3 more. Subscribe to see the full list
